4HF Biotec

4HF Biotec is a specialized biotechnology company focused on data-driven drug discovery and development in the field of oncology. The company utilizes a proprietary bioinformatics platform that integrates extensive clinical data, genomics, and drug sensitivity profiles from over 2,000 patient-derived xenograft (PDX) models and cell lines. By applying advanced analytics and artificial intelligence, 4HF Biotec identifies and validates novel therapeutic targets and predictive biomarkers to support the development of precision medicines. Their expertise spans various modalities, including small molecules and antibody-drug conjugates, aimed at addressing high unmet needs in solid tumors. The company provides strategic support to pharmaceutical partners for lead optimization and patient stratification to improve the success rates of clinical trials.